The Effect of Intraocular Pressure-Lowering Medication on Metastatic Uveal Melanomas.
Jan PalsHanneke W MensinkErwin BrosensRobert M VerdijkNicole C NausDion A ParidaensEmine KilicWishal D RamdasPublished in: Cancers (2021)
The use of topical prostaglandin or pilocarpine may increase the risk of metastatic UM and mortality compared to patients without prostaglandin or pilocarpine use. Therefore, use of IOP-lowering medication which increases aqueous humor outflow, should be avoided in patients with (presumed) UM.
Keyphrases
- end stage renal disease
- squamous cell carcinoma
- small cell lung cancer
- ejection fraction
- healthcare
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- cardiovascular events
- prognostic factors
- emergency department
- adverse drug
- cardiovascular disease
- coronary artery disease
- risk factors
- patient reported outcomes
- ionic liquid
- drug induced